News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

New Research Seeks to Crack the Code of Coral Reef Heat Resilience

Paul G. Allen Family Foundation

The Paul G. Allen Family Foundation today announced a suite of new grants supporting the next phase of groundbreaking research to identify naturally heat tolerant corals, accelerate corals’ evolution processes, improve restoration methods, and ultimately slow the decline of coral reefs. Coral reefs sustain more than a quarter of all marine life and drive $2.7 trillion dollars in economic benefits such as tourism and food each year. Climate change, however, is rapidly accelerating their path toward extinction, threatening the safety, livelihood, and food security of almost one billion people across the globe. “The rapid decline of coral reefs in the face of climate change makes finding adaptation techniques essential if corals are to survive,” said Jody Allen, co-founder and chair of the Paul G. Allen Family Foundation. “These grants build on the foundation’s longstanding commitment to coral reefs and support of applicable, scalable solutions to protect them. We are at a critical juncture with coral reefs facing extinction and the world must continue to invest in actionable research that ensures their preservation and long-term survival.” Coral reefs are among the most diverse and valuable ecosystems on the planet, but are facing extinction at a more accelerated rate than any other ecosystem on Earth. As a result of climate change, half of the world’s coral reefs have died in the last 50 years, and without drastic intervention to reduce carbon dioxide emissions, all will die by the end of this century under the current climate warming trajectory. By merging the latest advances in biomedical science, technology, and coral reef ecology, grantees will help corals survive while the world deals with the climate crisis. This suite of new research grants will provide field-deployable solutions to accelerate the natural evolution and identification of heat tolerant corals, and the scaling up of restoration strategies. The following research teams are receiving immediate support for their work. Professor Christian Voolstra at Konstanz University of Germany and a global academic team from Old Dominion University, Institute for Systems Biology, Australian Institute of Marine Science, and Pennsylvania State University are searching for corals with natural resilience to climate change, or “super corals,” so they can be prioritized for conservation and restoration efforts and studied to understand what makes a coral reef more heat tolerant. Professor Madeleine van Oppen and team at the Australian Institute of Marine Science are adapting the single-cell algae within corals to withstand greater temperatures and speed their natural evolutionary process. This grant will help bring their work from the lab to the field. Dr. Crawford Drury and team at the Hawaii Institute of Marine Biology, University of Hawaii, use selective breeding of corals to pursue additional methods of speeding their natural evolutionary processes. They will determine if reproduction of known thermally tolerant corals can produce high-temperature-tolerant offspring. Professor Peter Harrison and team at Southern Cross University, Australia are focused on enhancing the survival rate of juvenile corals to restore reefs. They will use this funding to scale up the restoration of degraded coral reefs by clearing reefs of seaweed and settling the coral larvae both on the reef and in new settlement designs. The foundation’s $7.2 million will support grantees to build on their successful initial research and enter into phase two, turning innovative ideas into scalable, sustainable solutions for coral reefs. This new suite of research grants is designed with a three-year timeline and focuses on applied solutions that can be deployed in the field by 2024. The Paul G. Allen Family Foundation has long supported the work of those preserving and protecting coral reefs from the impacts of climate change. In 2014, the Paul G. Allen Ocean Challenge awarded $4.3 million to van Oppen and Dr. Ruth Gates at the University of Hawaii to support their research, considered radical at the time, to assist the evolution of coral reef thermotolerance. The foundation is also a founding partner of the Global Fund for Coral Reefs, a blended finance mechanism that uses public and philanthropic funding to catalyze private investment in coral reef conservation and restoration. In addition to the foundation’s support of corals, in 2017 Paul G. Allen and Jody Allen’s private investment and management firm Vulcan Inc. partnered with Arizona State University, Planet Labs, National Geographic, and University of Queensland to launch the Allen Coral Atlas. The first of its kind global coral reef mapping and monitoring system provides a comprehensive and unprecedented level of high-resolution, comparable, and up-to-date data about the world’s reefs, and will complete its mapping mission this fall. Fact sheet and images for download available here. About Paul G. Allen Family Foundation For more than three decades the Paul G. Allen Family Foundation has focused on changing the trajectory of some of the world's toughest problems. Founded by philanthropists Jody Allen and the late Paul G. Allen, co-founder of Microsoft, the foundation initially invested in community needs across the Pacific Northwest with a focus on regional arts, underserved populations, and the environment. Today, the foundation supports a global portfolio of frontline partners working to preserve ocean health, protect wildlife, combat climate change, and strengthen communities. Contact Details Paul G. Allen Family Foundation +1 206-342-2230 press@pgafamilyfoundation.org Company Website https://www.pgafamilyfoundation.org/

June 02, 2021 07:02 AM Pacific Daylight Time

Article thumbnail News Release

LambdaTest rallies global investors raising US$16m Series B funding as it rapidly scales

Stockwood Strategy

Cloud-based browser testing platform LambdaTest today announced it has secured US$16 million in Series B funding led by Sequoia Capital India. Telstra Ventures, MENA region investor Wamda Capital and a leading sovereign wealth fund also joined the series B round. Founded in 2017 by Asad Khan and Jay Singh, San Francisco-based LambdaTest is a cloud-based testing infrastructure company that allows users to seamlessly test their websites’ and apps’ look, feel and performance on over 2,000 different browsers and by operating systems and device combinations. The proliferation of devices and browsers has made it increasingly complex for developers to test their websites and apps. LambdaTest solves this problem by enabling developers to run a variety of tests through their cloud-based platform, spotlight concerns, share immediately with teams and remedy issues quickly. LambdaTest exists to support the developer community to identify defects in code much earlier in the release cycle. These defects present one of the biggest challenges and costs facing businesses. Indeed, the cost of fixing these defects once in production and release is 30x higher than addressing earlier in the development cycle. Since its launch, LambdaTest has attracted over 500,000 developers in 132 countries who have performed more than 20 million tests. Customers include SMEs and Fortune 500 companies such as Xerox, Cisco, Microsoft, Deloitte, Media.net, Coca Cola, Trepp, SurveyMonkey, Capgemini, HBR, 23andme and Dashlane. Asad Khan, CEO of LambdaTest commented: “Companies are increasingly competing on customer experience 1 and as such are releasing software updates faster, more frequently to remain relevant. In doing so, there is a greater demand for continuous testing to ensure quality releases in the production environment. In just six short months since the series A round in 2020, LambdaTest has doubled revenues and increased customer numbers by 20%. In that time headcount has doubled in size from 70 people pre-Series A to 150 today across the engineering, sales, and customer success teams. Harshjit Sethi, Principal at Sequoia India commented: “As every company is becoming a software company and deployment cycles are shrinking, testing is becoming an increasingly important part of the software development cycle. Additionally testing is now happening earlier and earlier in the development cycle as part of the ‘Shift Left’ movement that companies like LambdaTest are enabling. Operating in a USD 35 billion market for testing software and services, LambdaTest has emerged as the go-to platform for its users in browser testing, evident from its best-in-class ratings across review sites. Sequoia Capital India is excited to continue partnering with the LambdaTest team as they execute on their vision of building an end-to-end testing system for developers to enable companies to release more reliable software faster.” The number of software tests run by developers has almost doubled from 12m to over 20m in six months at LambdaTest. As developers shift to cloud-based testing, this number will grow exponentially. This trend has been accelerated by the adoption of the Shift Left approach, as more developers are testing code early before they ship to the testing cycles. “LambdaTest’s vision is to empower 23 million developers and testers worldwide with a powerful, comprehensive and secure continuous quality test platform. Our upcoming product lines will enable tech teams to ship high quality code seamlessly boosting their release velocity” added Asad Khan. Steve Schmidt, General Partner at Telstra Ventures commented: “We have an opportunity to build a very large scale and independent testing company with a modern approach to software development and that’s very exciting. Lambdatest has already signed several customers in Australia without having any local presence and we look forward to helping them build out a local APAC team to meet this demand”. The funding advances LambdaTest’s commitment to scaling the testing ecosystem and building next-generation cloud infrastructure for users. To this end, LambdaTest is broadening its reach with the tester community by engaging with developers as it launches a suite of products in 2021 designed for them to perform tests on scale. “We’ve had an exciting period of growth and there is more to come as we expand our platform capabilities and go deeper in global markets. This funding round validates our efforts in building a robust cloud testing platform that is truly resonating with the testing and developer community globally. We pride ourselves in delivering a highly reliable, stable and secure infrastructure for them to achieve success. This success is born out in the numbers as our customers have been able to increase release velocity by over 60% and half the time to market” concluded Asad Khan. About LambdaTest LambdaTest is a cloud testing infrastructure company that allows users to run both manual and automated tests on their websites and webapps across 2000+ different browsers, browser versions and operating system environments. The platform has been used to perform over 20 million tests in just three years, and is now being used by over 500,000 users across 132 different countries. Contact Details LambdaTest Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.theeditldn.com/

June 02, 2021 05:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

American Kidney Fund Receives Support from Bayer to Expand Kidney Disease Education Among U.S. Veterans

American Kidney Fund

The American Kidney Fund (AKF) today announced support from Bayer for AKF’s effort to educate military veterans about the central role their kidneys play in their overall health and the importance of early detection to prevent or slow the progression of kidney disease. Bayer’s collaboration supports AKF’s existing partnership with the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to increase awareness of kidney disease among U.S. veterans and to support veterans who have been diagnosed with kidney disease. “About 500,000 U.S. veterans have kidney disease, and that number continues to trend upward by 6% each year, as it has for the past five years,” said LaVarne A. Burton, AKF president and CEO. “We are grateful for Bayer’s support of our work to reach out to veterans—a population that faces higher rates of kidney disease compared to the general public.” "A major risk factor for chronic kidney disease is type 2 diabetes and many veterans living with type 2 diabetes do not realize they are at risk," said Amit Sharma, M.D., FACP, FASN, FNKF, Vice President of Medical Affairs, Cardiovascular & Renal Division, Bayer. “Bayer is proud to support AKF’s work to educate America’s veterans on kidney disease risk factors, early detection and disease management, to help all veterans living with kidney disease live healthier lives.” Kidney disease is the fastest growing noncommunicable disease in the U.S., yet 90% of Americans, including veterans, with the early stages of kidney disease are unaware they have it because there are typically no symptoms until the later stages. Diabetes and hypertension cause 75% of all new cases of kidney disease. About the American Kidney Fund The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator and the Platinum Seal of Transparency from GuideStar. For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn. 11921 Rockville Pike, Suite 300, Rockville, MD 20852 Contact Details Ben Shannon Work: +1 202-559-2813 Mobile: +19193603039 AKF@jpa.com Company Website https://www.kidneyfund.org

May 27, 2021 09:00 AM Eastern Daylight Time

Article thumbnail News Release

British online store The Edit LDN transforms prized sneaker industry as sales soar

Stockwood Strategy

The UK’s leading online store for limited edition sneakers and high end streetwear The Edit Man London has become The Edit LDN. The name change reflects the rapidly growing female appeal for new and pre-loved sneakers and streetwear as sales grow 60% month-on-month in the last 12 months. The Edit LDN is an online consignment store that sells new and pre-loved goods from a variety of brands including Yeezy, Jordan, Louis Vuitton, Dior, Off-White, Supreme, Fear of God among others to a wide community of fashionistas, collectors and investors. Just as premium sites like Farfetch address the fashion world, The Edit LDN is the leading destination for limited edition sneakers and high end streetwear. They connect premium resellers with a highly engaged, price agnostic and eager audience. Through partnerships with styling services such as Thread.com and various concierge companies, THE EDIT LDN has expanded its community of buyers from TV and film celebrities to professional footballers and royal families around the world. Moses Rashid, founder and CEO of The Edit LDN commented: “As a brand we want to remain current and relevant to our community, our new name now fairly represents and embraces our diverse community but is true to its origins. We dropped the ‘Man’ from the name simply because the number of women buying had been steadily increasing since launch in January 2020 and passed 50% in March this year. It was the right thing to do.” The Edit LDN has established itself as a trusted source of authenticated and high quality new and pre-loved streetwear and sneakers. Their unabating focus on speed (to deliver purchased goods), customer service engagement and ensuring all goods are authenticated has been testament to the growth of the platform and community. “We set out to create a destination that opens up and levels up the opportunity for anyone wishing to own extremely limited edition goods. Essentially we make Inaccessible, accessible. Previous means to buy these goods have been riddled with issues such as sending payments to random resellers found on social media, authenticity issues when buying online and long delivery times on purchases from global marketplaces. The Edit LDN addresses all these concerns and is transforming the customer experience and industry simultaneously, added Moses ”. In 2021 (to April), The Edit LDN attracted more traffic, transactions and revenue than in their first year of trading (2020). With 60% month-on-month growth and mounting interest, the business is set to take-off. “We’re regularly selling sneakers and streetwear worth £1,500 each. Recently, we sold a Gucci TNF jacket for £9,200. It’s not only the variety of goods we offer but the speed at which we send purchases. Just last year we managed to source and sell 44 Playstation 5 games consoles to the England U21 football team within 24 hours, literally dispatching them in Ubers to their homes” said Moses. Looking ahead, Moses added: “This is a marketplace worth $6b a year globally and will grow 5x by 2030. By the end of this year, The Edit LDN will be worth £10m and given the hyper growth rate of our sales and revenues, we will 3x our valuation by the end of 2022 for sure. In meeting the needs of this rapid scaling, we will seek to raise funds this year to propel us as we launch in new markets”. The Edit LDN has its community and social conscious front of mind. They have raised funds and awareness against gun crime, mental health and sustainability issues. In 2020, the company collaborated with the artist McCrow as part of the One Less Gun campaign to create a sneaker with bullet shells from an AK-47 rifle. Working with Gary James McQueen in aid of MIND mental health charity, they raised funds with an exclusive T-shirt drop featuring the famous McQueen Vanitas skull. In owning their sustainability agenda, they turned their focus to the circular economy by selling pre-owned (or pre-loved) goods through the platform. In addition to this, they are a paperless company and only ship products using recycled packaging. “At the heart of The Edit LDN proposition is a focus on social and economic issues. These are matters that are important to us and our community, so we recognise that we’re in a super hot market right now so we want to use our platform to make a long lasting impact where possible” concluded Moses. About The Edit LDN Founded in 2020, The Edit LDN has quickly become the UK’s leading online consignment store for limited edition sneakers and high end streetwear, both new and pre-loved items. Their innovative platform connects premium resellers to a global audience offering a deluxe experience from discovery, packaging and delivery. Brands include Jordan, Yeezy, Louis Vuitton, Dior, Off-White, Supreme, Fear of God among others. The platform is fast becoming synonymous with speed of service, authenticity, diverse selection of secure payment methods, and first class customer service. The Edit LDN is the leading destination for resellers and their premium sneakers and streetwear. Through partnerships with styling services such as Thread.com and various concierge companies, The Edit LDN has a community of buyers celebrities to professional footballers and royal families around the world. Contact Details The Edit LDN Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.theeditldn.com/

May 27, 2021 05:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

Elsevier Supports the State of California in Expanding COVID-19 Online Learning Program for Registered Nurses

Elsevier

In response to the increased need for skilled healthcare workers during the pandemic, many hospitals in California are calling upon adjunct nursing staff that don’t typically work in the ICU to offer additional support in the care of critically ill patients Elsevier, a global leader in research publishing and information analytics, announced today that it is working with the State of California Emergency Medical Services (EMS) Authority and the American Association of Critical-Care Nurses (AACN) to expand its COVID-19 online training for adjunct nursing staff who can provide additional support in the intensive care units (ICU) during the pandemic. The week-long online curriculum, created by the AACN, is designed to help adjunct nursing staff who don’t typically work in the ICU to enhance their clinical skills and knowledge on caring for patients with the novel coronavirus, SARS-CoV-2. Registered nurses in California can learn more about this continuing education training option and how to register by visiting the EMS Authority’s website. John Danaher, MD, President, Clinical Solutions, Elsevier, said: “We are continuing to work with the State of California to support frontline workers who are playing such an important role in our local communities. Hundreds of newly trained nurses in California have completed the initial training program and are providing additional support in ICUs across the state. We look forward to our continued collaboration and doing everything we can to support patient care.” Some of the learning modules included in the expanded program include Critical Care Patient Management, Acute Coronary Syndrome (ACS), Assessing and Managing Respiratory Failure, and Managing Oxygenation and Ventilation. Elsevier is committed to supporting clinicians and students and helping them improve outcomes. In April 2020, Elsevier launched its COVID-19 Healthcare Hub, which provides free access to toolkits, expert insights, research resources and COVID-19 guidelines. The Hub’s resources include evidence-based clinical overviews, drug monographs, care plans, order sets, and procedure videos for clinicians delivering care and information to patients. Clinicians will also find the latest information and guidelines from government health agencies, medical societies and public health organizations for diagnosis, testing and treatment of COVID-19 patients. To help address the wave of misinformation about the virus and support clinicians in India, Elsevier recently launched the India Covid-19 Healthcare Hub. The website includes short synoptic clinical overviews, medication information, and easy-to-understand videos and instructions for patients. Additionally, AACN hosts a COVID-19 Resources page on its association site that provides free access to clinical and supportive resources ensuring nurses have the information and support to best care for their patients and themselves throughout the pandemic. About the American Association of Critical-Care Nurses For more than 50 years, the American Association of Critical-Care Nurses (AACN) has been dedicated to acute and critical care nursing excellence. The organization’s vision is to create a healthcare system driven by the needs of patients and their families in which acute and critical care nurses make their optimal contribution. AACN is the world’s largest specialty nursing organization, with more than 130,000 members and over 200 chapters in the United States. American Association of Critical-Care Nurses, 27071 Aliso Creek Road, Aliso Viejo, CA 92656; 949-362-2000; www.aacn.org; facebook.com/aacnface; twitter.com/aacnme About Elsevier As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders. Elsevier employs 8,100 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our 2,500+ digitized journals, including The Lancet and Cell; our 40,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com Contact Details American Association of Critical-Care Nurses – Communications Kristie Aylett kristie.aylett@aacn.org Elsevier Communications – Vice President, Global Health Markets Teresa Mueller +31620987384 t.mueller@elsevier.com

May 26, 2021 01:45 PM Pacific Daylight Time

Article thumbnail News Release

Is it Possible to Kill Corona Virus from Luggage Surfaces in Just 5 Seconds? University Study Says "Yes"

WarpUV

Following extensive testing, the Microbial Pathogenesis Laboratory at Tel Aviv University has concluded the WarpUV ® AirFort® luggage disinfection system can eradicate coronaviruses in just five seconds. For airports, baggage handlers and air passengers, the study findings show air travel can be safer again because luggage surface areas that typically pass through many hands on their way to, from and at the airport, and susceptible to airborne transmissible droplets, can be safely and quickly sanitized. Prof. Anat Herskovits, a world-renowned microbiologist, Vice Chair of the Shmunis School of Biomedicine and Cancer Research, and President of the Israel Society of Microbiology, tested the ability of the WarpUV AirFort® technology to kill high concentrations of coronaviruses. “Our results concluded that after five seconds of UV irradiation, more than 99 percent of the viruses were eradicated,” Prof. Herskovits said. “I feel confident that WarpUV has developed an effective solution for luggage disinfection.” Resources: Hear audio quote from Prof. Herskovits (.wav,.mp3) Post-COVID-19 Air Travel/Bio-Security survey, May 2021 Breakthrough Rapid-Action Coronavirus and Bacteria Disinfection Technology for Passenger Luggage at Airports Stops Local Outbreaks from Becoming Global Pandemics AirFort® is designed to rapidly kill viruses, bacteria, and spores from surface contamination of carry-on and checked bags, personal items and oversized bags and parcels, protecting baggage handlers, aviation staff, and the general public. It utilizes a proprietary array of ultraviolet lights designed to achieve all-angle “360° x 360°” disinfection of all baggage surfaces. While floor UV cleaners and other disinfection agents such as sprays are being implemented globally, AirFort focuses on luggage – one of the means that the International Air Transport Association (IATA), European Union Aviation Air Safety Agency (EASA), and the U.S. Department of Homeland Security identified as a possible critical path for viruses and bacteria to infect and spread. By eradicating these harmful elements before and after flights, WarpUV has an important role in stopping the spread and future spread of pandemics which are imminent threats as described by the EU, WHO, and the World Economic Forum. About WarpUV Warp Technologies and its AirFort® devices are the frontline of prevention of the spread of pandemic by luggage and baggage in airports worldwide and serve as a “disinfection firewall” for continents, countries, and regions. The company was formed in 2020 by veteran Israeli entrepreneurs Amir Fischer, Eitan Haimovich, and Gil Luxenbourg. For more information, visit www.warpUV.com. Contact Details Rainier Communications Alan Ryan +1 508-577-6635 alanryan@rainierco.com Rainier Communications Joanne Stanway +19782731473 jstanway@rainierco.com Company Website https://www.warpuv.com/

May 26, 2021 02:30 PM Eastern Daylight Time

Article thumbnail News Release

Dogs Don’t Know, Heat Can Hurt: How to Recognize the Warning Signs of Exercise-Induced, Heat Related Illness

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/Q9_KZTWQXCU It’s summer, and everyone wants to be outside with their dogs. But it’s hot, and when our best friends are chasing frisbees, balls, and running they don’t always know they’re overheating. If their core body temperatures rise faster than they can cool off, dogs may suffer from Heat Related Illness (HRI). National Heat Awareness Day is May 28, 2021, and EUKANUBA™ wants you to learn how to keep your dog safe while exercising this summer. EUKANUBA™, a premium dog food brand specializing in high-performance nutrition for sporting and working dogs, is drawing attention to canine exercise-induced heat related illness (HRI) by conducting a nationwide media tour in conjunction with D S Simon Media and Your Update TV featuring Dr. Joe Spoo, Veterinarian, Eukanuba™. During the nationwide media tour and Public Service Announcement (PSA) Dr. Spoo discussed: What is a Heat Related Illness The Three Stages: Heat Stress, Heat Exhaustion, and Heat Stroke. How to recognize the HRI warning signs in your dog. How dogs naturally cool down. What type of dogs are at risk. Ways to keep them cool while exercising and having fun. The importance of hydration For more information please visit: EUKANUBA.com About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

May 26, 2021 12:00 PM Eastern Daylight Time

Video
Article thumbnail News Release

American Kidney Fund Applauds Texas for Enacting Protections for Living Organ Donors

American Kidney Fund

The American Kidney Fund (AKF) commends Texas Governor Greg Abbott for signing into law important protections for living organ donors. H.B. 317 prohibits life, disability and long-term care insurers from discriminating against living organ donors by declining or limiting coverage due to their status as an organ donor, charging living organ donors more for a policy, and from precluding a person from donating all or part of an organ as a condition of their policy. AKF worked closely with bipartisan H.B. 317 sponsors Rep. Andrew Murr in the House and Sen. Boris L. Miles—a kidney transplant recipient himself—in the Senate to move the bill through the Texas Legislature. AKF is spearheading the nationwide effort to pass living donor protections at the state level, and since 2019, 16 states have signed these bills into law, including New Jersey, Washington, Pennsylvania and Kentucky earlier this year. “The American Kidney Fund applauds Texas for enacting legislation that will ensure no one who chooses to make the lifesaving gift of organ donation falls victim to discriminatory insurance practices because of that decision,” said LaVarne A. Burton, AKF president and CEO. “Governor Abbott’s signature on this bill will remove barriers for living organ donors and ultimately will save lives by increasing the number of kidneys and other organs available for Texans who are awaiting transplantation.” Increasing living donor protections is a cornerstone of AKF’s policy agenda, and earlier this year, AKF released its first annual State of the States: Living Donor Protection Report Card, which measures seven types of legislation states should enact to provide protections for living organ donors and encourage living donations. In the absence of federal legislation to protect living donors, there is an uneven patchwork of protections across the nation, with some states providing no protections at all. H.B. 317 is Texas’ second piece of living donor legislation, moving the state’s Report Card grade up from a D to a C. “Even as we recognize the significance of Texas’ enactment of this legislation, we recognize that there is much more that needs to be done nationwide to secure living donor protections,” said Burton. At the federal level, AKF continues to advocate for the Living Donor Protection Act of 2021 (H.R.1255/S.377), which would ensure a uniform baseline of living donor protections nationwide. Most transplanted organs are from deceased donors, but patients may also receive organs from living donors. Living donation offers an alternative for individuals awaiting transplantation from a deceased donor and increases the existing organ supply. Transplants from living donors generally have fewer complications than deceased-donor transplants and a longer survival of the donor organ. There are more than 107,000 Americans on the organ transplant waiting list and nearly 93,000 of them, or 86%, are waiting for a kidney. More than 8,300 Texans are on the kidney transplant waiting list. Of the 23,644 kidney transplants performed in the U.S. in 2020, just 5,234 were made possible by living organ donors. In Texas, 613 of 2,242 kidney transplants were from living donors. AKF provides long-term financial assistance that makes transplants and post-transplant care possible for low-income dialysis patients. In 2020, AKF grants helped 1,615 people nationwide receive kidney transplants—7% of all kidney transplants performed in the United States last year. AKF’s program helps post-transplant patients for their full insurance plan year, ensuring continuity of care. About the American Kidney Fund The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator and the Platinum Seal of Transparency from GuideStar. For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn. Contact Details Ben Shannon Work: +1 202-559-2813 Mobile: +19193603039 AKF@jpa.com Company Website http://www.kidneyfund.org/

May 25, 2021 11:00 AM Eastern Daylight Time

Article thumbnail News Release

American Kidney Fund Expands 2021 Class of Corporate Members Committed to Fighting Kidney Disease

American Kidney Fund

The American Kidney Fund (AKF) today announced four new Members joining the 2021 class of its Corporate Membership Program. The Corporate Membership Program has provided AKF with nearly $500,000 in funding, which is being used for critical educational programming and the development of resources and information to help save the lives of those affected by kidney disease. AstraZeneca and Vertex Pharmaceuticals have joined as Patron-level Members, Dicerna Pharmaceuticals has joined as an Advocate-level Member, and Reata Pharmaceuticals, Inc. has joined as a Friend-level Member. “Our Corporate Membership Program provides AKF with funding that is indispensable as we work with and for patients, caregivers, living organ donors and health care providers in the fight against kidney disease,” said LaVarne A. Burton, AKF president and CEO. “We are proud to welcome the newest 2021 Corporate Members in our program and are grateful for their commitment to improve the lives of Americans living with and at risk for kidney disease.” The 2021 class of AKF Corporate Members now includes: Champion Level: Amgen and GlaxoSmithKline (GSK) Patron Level: Alexion Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Ardelyx, Inc., AstraZeneca, Horizon Therapeutics plc, Mallinckrodt plc, Otsuka America Pharmaceutical, Inc., Quest Diagnostics, Inc., Sanofi Genzyme and Vertex Pharmaceuticals Advocate Level: Apellis Pharmaceuticals, Inc., Aurinia Pharmaceuticals Inc., Biotechnology Innovation Organization (BIO), Chinook Therapeutics, Inc., Dicerna Pharmaceuticals, Pharmaceutical Research and Manufacturers of America (PhRMA) and Vifor Pharma Group Friend Level: Omeros Corporation, OPKO Health and Reata Pharmaceuticals, Inc. AKF has a long history of outstanding stewardship of the donated dollar, giving Corporate Members the confidence that their investment in AKF will have the maximum impact on the lives of those affected by kidney disease. With 97 cents of every donated dollar spent on patients and programs, not overhead, AKF directly touches the lives of more people with kidney disease than any other nonprofit. AKF received its 19th consecutive 4-star rating from Charity Navigator in 2020, making it one of just three nonprofits nationwide to have received Charity Navigator’s top rating every year since the rating system began. The Corporate Membership Program is open to institutional partners that support AKF’s mission of fighting kidney disease and helping people live healthier lives. For more information, contact Daniel Green, corporate engagement manager, at dgreen@kidneyfund.org or 301-984-6675. About the American Kidney Fund The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator and the Platinum Seal of Transparency from GuideStar. Contact Details Ben Shannon Work: +1 202-559-2813 Mobile: +19193603039 AKF@jpa.com Company Website http://www.kidneyfund.org/

May 25, 2021 10:00 AM Eastern Daylight Time

1 ... 162163164165166 ... 191